Insmed Up Over 30% Following FDA Decision By: Benzinga via Benzinga June 18, 2014 at 08:24 AM EDT Insmed (NASDAQ: INSM) shareholders are having a big day. Shares are up over 33 percent after the company announced that the FDA ... Read More >> Related Stocks: Insmed Inc